The Diagnostic Imaging Market will increase at a CAGR of 5.2% from 2019 to 2025 to reach $35.65 billion by 2025. Factors such as growing prevalence of chronic diseases, increasing geriatric population, technological advancements in imaging modalities, growing number of hospitals and diagnostic imaging centers, and improving healthcare infrastructure are expected to drive the growth of diagnostic imaging market. Moreover, emerging economies, growing medical tourism, and development of multi-modality imaging systems offer significant growth opportunities for market players during the forecast period.
Increasing geriatric population fuels the growth of the global diagnostic imaging market
The aging population is a global concern and its share in total population is growing in most of the countries. This increase is attributed to decline in fertility rate and improvement in quality of healthcare leading to greater survival rates.
According to World Bank, the global elderly population increased from 530 million in 2010 to 655 million in 2017, representing a growth of 24%. According to a report published by United Nations in 2017, the global population aged 60 years or over is expected to reach 2.1 billion by 2050. Also, the number of persons aged 80 years or above is projected to increase threefold between 2017 and 2050, rising from 137 million to 425 million, globally.
Growing aging population is linked with the rising prevalence of chronic diseases which in turn is likely to increase the number of hospital admissions. Further, aging often leads to problem of falls - which is one of the most common causes of injury and hospital admissions in the geriatric population. According to CDC, in 2015, medical cost associated with the falls in the U.S. exceeded USD 50 billion. In a year, in the U.S., at least 300,000 older people are hospitalized for hip fractures. Thus, increasing elderly population and rising prevalence of chronic diseases along with high fall rates will lead to growth in demand for diagnostic imaging.
Click here to Download Sample Report Now!!
Key Findings in the global diagnostic imaging market study:
X-ray imaging dominates the global diagnostic imaging market, by product
The diagnostic imaging market study provides detailed insights on X-ray imaging systems, computed tomography (CT) scanners, ultrasound imaging systems, magnetic resonance imaging (MRI) systems, and nuclear imaging systems. X-ray imaging systems lead the diagnostic imaging market owing to its low cost, and the ability of X-rays to produce accurate images that provide a clear idea of the musculoskeletal system. The growth of this segment is supported by the increasing demand for mobile X-ray systems, growth in the number of hospitals and diagnostic centers especially in emerging countries, advances in digital technology, painless and non-invasive procedures, and low price of x-rays as compared to other modalities.
Hospitals lead the global diagnostic imaging market, by end user
Based on the end user, the market is segmented into hospitals, diagnostic imaging centers, and others (including pharmaceutical & biotechnology companies, academic & research centers, sports academies, and CROs). Currently, hospitals comprise the largest share however, adoption of imaging systems by the diagnostic centers is expected to grow at the highest CAGR during the forecast period. Factors such as increasing number of private imaging centers fueled by the rising demand for diagnostic imaging procedures is expected to drive the growth of this end user segment.
Asia-Pacific: Fastest Growing Regional Market
The diagnostic imaging market is dominated by North America. However, Asia-Pacific region is expected to register the highest growth during the forecast period. Increasing number of hospitals and diagnostic centers, favorable government policies and initiatives, increasing healthcare expenditure, improving infrastructure, aging population, and growing focus of key players in this region are the key factors expected to fuel growth of this market in APAC.
Key Players
The key players in the global diagnostic imaging market are GE Healthcare (U.S.), Siemens Healthineers (Germany), Koninklijke Philips N.V. (The Netherlands), Canon Medical Systems Corporation (Japan), Hitachi Ltd. (Japan), Carestream Health, Inc. (U.S.), Esaote S.p.A (Italy), Hologic, Inc. (U.S.), Fujifilm Corporation (Japan), Samsung Medison (South Korea), and Shimadzu Corporation (Japan), among others.
Future Outlook
Utilization of 3D, 4D technologies, multi-modality imaging systems, and integration of Artificial Intelligence (AI) in imaging modalities are some of the emerging trends in diagnostic imaging field. The growing application of AI and machine learning to the field of medical imaging is expected to bring a myriad of benefits, including augmentation and improvements in diagnosis. Moreover, AI will be an asset to the radiologists when it comes to workflow and diagnostic efficiency, as well as a vital tool that fosters a paradigm shift in predictive healthcare.
Key questions answered in the report:
Hospitals accounted for the largest share of the global diagnostic imaging market
Diagnostic Imaging market favours both larger and local manufacturers that compete in multiple segments
Recent partnerships, acquisitions, and expansions have taken place in the global diagnostic imaging market
We are in the phase of updating this report by analysing the impact of COVID-19 on this market.
1 Introduction
1.1 Market Scope
1.2 Currency
1.3 Limitations
1.4 Key Stakeholders
2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Market Size Estimation
3 Executive Summary
4 Market Insights
4.1 Introduction
4.2 Drivers
4.2.1 Increasing Investments and Funding By Government Bodies for Modernization of Imaging Facilities
4.2.3 Growth in Number of Diagnostic Imaging Centers
4.2.4 Rising Prevalence of Cancer
4.2.5 Increasing Geriatric Population and Growing Incidence of Chronic Diseases
4.2.6 Technological Advancements in Diagnostic Imaging Modalities
4.2.7 Increasing Preference for Minimally Invasive Treatments
4.2.8 Growing Focus on Preventive Care
4.3 Restraints
4.3.1 High Cost of Diagnostic Imaging Systems
4.3.2 Unfavorable Healthcare Reforms in the U.S.
4.3.3 Shortage of Helium (an essential component of MRI)
4.4 Opportunities
4.4.1 High Growth Opportunities in Emerging Countries
4.4.2 Development of Low-Cost Imaging Systems
4.4.3 Growing Medical Tourism
4.5 Challenges
4.5.1 Increasing Adoption of Refurbished Diagnostic Imaging Systems
4.5.2 Dearth of Trained Personnel
5 Diagnostic Imaging Market, By Product
5.1 Introduction
5.2 X-Ray Imaging Systems
5.2.1 X-Ray Imaging Systems Market, By Technology
5.2.1.1 Digital Imaging
5.2.1.1.1 Direct Radiography
5.2.1.1.2 Computed Radiography
5.2.1.2 Analog Imaging
5.2.2 X-Ray Imaging Systems Market, By Portability
5.2.2.1 Stationary
5.2.2.1.1 Floor-To-Ceiling Mounted Systems
5.2.2.1.2 Ceiling-Mounted Systems
5.2.2.2 Portable
5.2.2.2.1 Mobile X-Ray Systems
5.2.2.2.2 Handheld X-Ray Systems
5.3 Magnetic Resonance Imaging (MRI)
5.3.1 MRI Systems Market, By Architecture
5.3.1.1 Closed MRI Systems
5.3.1.2 Open MRI Systems
5.3.1.3 Standard Bore MRI
5.3.1.4 Wide-Bore MRI
5.3.2 MRI Systems Market, By Field Strength
5.3.2.1 High- and Very-High Field MRI Systems (1.5T to 6T)
5.3.2.2 Low-To-Mid-Field MRI Systems (<1.5T)
5.3.2.3 Ultra-High-Field MRI Systems (7T and Above)
5.4 Ultrasound Imaging Systems
5.4.1 Ultrasound Imaging Systems Market, By Technology
5.4.1.1 2D Imaging Systems
5.4.1.2 3D and 4D Imaging Systems
5.4.1.3 Doppler Imaging
5.4.2 Ultrasound Imaging Systems Market, By Portability
5.4.2.1 Trolley/Cart-Based Ultrasound Systems
5.4.2.2 Compact/Portable Ultrasound Systems
5.4.2.3 Point-of-care Ultrasound Systems
5.5 Computed Tomography (CT) Scanners
5.5.1 Computed Tomography Scanners Market, By Slice Type
5.5.1.1 High-Slice CT Scanners
5.5.1.2 Mid-Slice CT Scanners
5.5.1.3 Low-Slice CT Scanners
5.5.2 Computed Tomography Scanners Market, By Portability
5.5.2.1 Stationary CT Scanners
5.5.2.2 Portable CT Scanners
5.6 Nuclear Imaging Systems
5.6.1 SPECT Systems, by type
5.6.1.1 Hybrid SPECT Systems
5.6.1.2 Standalone SPECT Systems
5.6.2 Hybrid PET Systems
6 Diagnostic Imaging Market, by Application
6.1 Introduction
6.2 X-Ray Imaging Systems
6.2.1 General Radiography
6.2.2 Dental
6.2.3 Mammography
6.3 MRI Systems
6.3.1 Brain and Neurological MRI
6.3.2 Spine and Musculoskeletal MRI
6.3.3 Vascular MRI
6.3.4 Pelvic and Abdominal MRI
6.3.5 Breast MRI
6.3.6 Cardiac MRI
6.4 Ultrasound Systems
6.4.1 Radiology/General Imaging
6.4.2 Obstetrics/Gynecology (OB/GYN)
6.4.3 Cardiology
6.4.4 Vascular
6.4.5 Urology
6.4.6 Other Applications
6.5 CT Scanners
6.5.1 Cardiology
6.5.2 Oncology
6.5.3 Neurology
6.5.4 Other Applications
6.6 Nuclear Imaging Systems
6.6.1 Cardiology
6.6.2 Oncology
6.6.3 Neurology
6.6.4 Other Applications
7 Diagnostic Imaging Market, by End User
7.1 Introduction
7.2 Hospitals
7.3 Diagnostic Imaging Centers
7.4 Other End Users
8 Diagnostic Imaging Market, By Region
8.1 Introduction
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 RoE
8.4 Asia-Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 RoAPAC
8.5 Rest of the World
8.5.1 Latin America
8.5.2 Middle East & Africa
9 Competitive Landscape
9.1 Introduction
9.2 Company Benchmarking
9.3 Market Share Analysis
10 Company Profiles
10.1 Carestream Health
10.1.1 Business Overview
10.1.2 Financial Overview
10.1.3 Product Portfolio
10.1.4 Strategic Developments
10.2 Esaote S.P.A
10.2.1 Business Overview
10.2.2 Financial Overview
10.2.3 Product Portfolio
10.2.4 Strategic Developments
10.3 Fujifilm Holdings Corporation
10.3.1 Business Overview
10.3.2 Financial Overview
10.3.3 Product Portfolio
10.3.4 Strategic Developments
10.4 GE Healthcare
10.4.1 Business Overview
10.4.2 Financial Overview
10.4.3 Product Portfolio
10.4.4 Strategic Developments
10.5 Hitachi Ltd.
10.5.1 Business Overview
10.5.2 Financial Overview
10.5.3 Product Portfolio
10.5.4 Strategic Developments
10.6 Koninklijke Philips N.V.
10.6.1 Business Overview
10.6.2 Financial Overview
10.6.3 Product Portfolio
10.6.4 Strategic Developments
10.7 Siemens AG
10.7.1 Business Overview
10.7.2 Financial Overview
10.7.3 Product Portfolio
10.7.4 Strategic Developments
10.8 Shimadzu Corporation
10.8.1 Business Overview
10.8.2 Financial Overview
10.8.3 Product Portfolio
10.8.4 Strategic Developments
10.9 Samsung Medison
10.9.1 Business Overview
10.9.2 Financial Overview
10.9.3 Product Portfolio
10.9.4 Strategic Developments
10.10 Canon Medical Systems Corporation
10.10.1 Business Overview
10.10.2 Financial Overview
10.10.3 Product Portfolio
10.10.4 Strategic Developments
11 Appendix
We are in the phase of updating this report by analysing the impact of COVID-19 on this market.
We are in the phase of updating this report by analysing the impact of COVID-19 on this market.
Published Date: May-2023
Published Date: Feb-2023
Published Date: May-2022
